Dialectical Behavior Therapy Applications with a Substance Use Population

Presented By DANIEL KOBOSKY, LCSW, NCAC1

Provided by RiverMend Health Institute

Scroll to the Bottom of this Information to Begin this Course

Release date: February 25, 2016

Valid through: February 25, 2017

Specialty: Addiction, DBT Therapy

Topic: Dialectical Behavioral Therapy and Substance Abuse

Media: Internet

Estimated Time to Complete Activity: 90 minutes

Target Audience

This CE activity is intended for all.

Program Overview

DBT was developed by Marsha Linehan for treating individuals with borderline personality disorder. The skills used in DBT help individuals struggling with chemical dependency issues to challenge thoughts and perceptions, tolerate emotions, identify emotions that may lead to relapse, repair relationships destroyed by addiction as well as develop mindfulness and build skills for self-care.

Learning Objectives

Upon completion of this activity, participants should be better able to: 

  1. Describe DBT language of treatment interfering behaviors.
  2. List four core DBT skill modules and how skills apply to chemical dependency and relapse prevention.

Continuing Education

APA, American Psychological Association

RiverMend Health Institute is approved by the American Psychological Association to sponsor continuing education for psychologists.  RiverMend Health Institute maintains responsibility for this program and its content.

APA CE credit Awarded: 1.5

NAADAC, The Association for Addiction Professionals

RiverMend Health Institute is a NAADAC Approved Continuing Education Provider and may offer NAADAC- National Certification Commission approved hours for events that meet NAADAC requirements. Provider # 867.

NAADAC Continuing Education Units awarded: 1.5

NBCC, National Board of Certified Counselors

The RiverMend Health is an NBCC-Approved Continuing Education Provider (ACEP™) and may offer NBCC approved clock hours for events that meet NBCC requirements. The ACEP solely is responsible for all aspects of the program. Provider #6573.

NBCC CE credit Awarded: 1.5

CBBS, California Board of Behavioral Sciences

This course meets the qualifications for continuing education credit for MFTs, LPCCs, LEPs and/or LCSWs as required by the California Board of Behavioral Sciences. RiverMend Health Institute Provider #4688.

CBBS CE credit awarded: 1.5

CDR, Commission on Dietetic Registration

RiverMend Health Institute is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians registered (CDR). Registered dietitians (RDs) and dietetic technicians registered (DTRs) will receive continuing professional education units (CPEUs) for the completion of this program. CDR Provider #R1656.

CDR CPEU awarded: 1.5

Faculty

DANIEL KOBOSKY, LCSW, NCAC1

DANIEL KOBOSKY, LCSW, NCAC1

Daniel Allen Kobosky, LCSW, NCAC1 is the Executive Director of Positive Sobriety Institute and is a licensed Clinical Social Worker, Nationally Certified Addiction Counselor with 20+ years experience providing individual and group counseling in communities ranging from homeless populations to professional level staff with chemical dependency and mental health issues.

Daniel Allen Kobosky started his education at Illinois State University before deciding to relocate to Chicago and continue his education at University of Illinois at Chicago. Daniel Allen Kobosky obtained a BA in psychology with a minor in sociology. He obtained his Masters in Social work from Loyola University in 1996.

Since that time Daniel Allen Kobosky has worked with many populations including a children in residential treatment for behavior disorders, developing Chicago’s only HIV+ addictions program with Heartland Alliance and providing in home therapeutic services to at risk pregnant women with the city of Chicago prior working with Dr. Daniel Angres in Oak Park providing treatment to addicted professionals.

Recently, Daniel Allen Kobosky obtained his National Certification for Addiction Counseling as well as completed training with the University of Washington’s Dialectical Behavior Therapy program. During this time, Daniel Allen Kobosky provided individual and group DBT therapy with Group Health to reduce inpatient hospitalizations of high risk and high need populations. Daniel Allen Kobosky returned to Chicago in 2013 to work with Dr. Daniel Angres and is now is the Executive Director at Positive Sobriety Institute.

Disclosures of Conflicts of Interest

DANIEL KOBOSKY, LCSW, NCAC1
  • No financial relationships relevant to this field of study.

Instructions for Participation and Credit

There are no fees for participating and receiving credit for this activity. During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the post-test and the evaluation form. If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.